Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer

Raffaele Addeo; Alessandro Sgambato; Gregorio Cennamo; Liliana Montella; Vincenzo Faiola; Alberto Abbruzzese; Elena Capasso; Luigi Leo; Gerardo Botti; Michele Caraglia; Salvatore Del Prete

doi:10.3816/cbc.2010.n.039

Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.039 ◽

2010 ◽

Vol 10 (4) ◽

pp. 301-306 ◽

Cited By ~ 56

Author(s):

Raffaele Addeo ◽

Alessandro Sgambato ◽

Gregorio Cennamo ◽

Liliana Montella ◽

Vincenzo Faiola ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Elderly Patients ◽

Oral Administration ◽

Low Dose ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

A multicenter phase II study of epirubicin with low-dose trastuzumab as a first line treatment in Her-2 overexpressing metastatic breast cancer: preliminary results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80420-9 ◽

2006 ◽

Vol 4 (2) ◽

pp. 165

Author(s):

M. Zilli ◽

De Tursi ◽

C. Carella ◽

E. Ricevuto ◽

P. Marchetti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Her 2 ◽

First Line Treatment

Download Full-text

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer

Oncotarget ◽

10.18632/oncotarget.18539 ◽

2017 ◽

Vol 8 (45) ◽

pp. 79527-79536 ◽

Cited By ~ 2

Author(s):

Jian Zhang ◽

Leiping Wang ◽

Zhonghua Wang ◽

Biyun Wang ◽

Jun Cao ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Triple Negative ◽

Metastatic Breast ◽

Oral Cyclophosphamide ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

P101 A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer

The Breast ◽

10.1016/s0960-9776(07)70161-3 ◽

2007 ◽

Vol 16 ◽

pp. S41

Author(s):

M. De Tursi ◽

C. Carella ◽

E. Ricevuto ◽

A. Gennari ◽

C. Orlandini ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Her 2 ◽

First Line Treatment

Download Full-text

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

European Journal of Cancer ◽

10.1016/j.ejca.2011.06.018 ◽

2011 ◽

Vol 47 (16) ◽

pp. 2387-2395 ◽

Cited By ~ 61

Author(s):

Xavier Pivot ◽

Andreas Schneeweiss ◽

Shailendra Verma ◽

Christoph Thomssen ◽

José Luis Passos-Coelho ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Elderly Patients ◽

Metastatic Breast ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Locally Recurrent ◽

First Line Treatment

Download Full-text

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer

Oncology ◽

10.1159/000127414 ◽

2007 ◽

Vol 73 (3-4) ◽

pp. 228-237 ◽

Cited By ~ 18

Author(s):

D. Hess ◽

D. Köberle ◽

B. Thürlimann ◽

O. Pagani ◽

A. Schönenberger ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Elderly Patients ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu–Negative Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.017 ◽

2008 ◽

Vol 8 (2) ◽

pp. 162-167 ◽

Cited By ~ 6

Author(s):

Orlando Silva ◽

Gilberto Lopes ◽

Daniel Morgenzstern ◽

Christopher Lobo ◽

Philomena Doliny ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Low Dose ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer

Annals of Oncology ◽

10.1023/a:1008384820279 ◽

2000 ◽

Vol 11 (2) ◽

pp. 229-230 ◽

Cited By ~ 6

Author(s):

J.E. Kurtz ◽

G. Deplanque ◽

C. Borel ◽

C. Mathelin ◽

G. Prévost ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Elderly Patients ◽

Metastatic Breast ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Finding Study ◽

Dose Finding Study ◽

First Line Treatment

Download Full-text

413 POSTER A multicenter phase II study of Epirubicin (E) with low-dose herceptin (LD-H) as a first line treatment in HER-2 overexpressing metastatic breast cancer (MBC): Preliminary results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80711-6 ◽

2005 ◽

Vol 3 (2) ◽

pp. 116

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Her 2 ◽

First Line Treatment

Download Full-text

Low dose sequential docetaxel-capecitabine chemotherapy as first-line treatment of metastatic breast cancer (mbc)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.12007 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 12007-12007

Author(s):

M. Hafeez ◽

A. Shaharyar ◽

A. I. Masood ◽

M. Zikria ◽

A. Usman ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Faculty of 1000 evaluation for Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717976445.793471388 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Phase 3 ◽

First Line Treatment

Download Full-text